Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
0.6075
+0.0435 (7.71%)
At close: Sep 8, 2026, 4:00 PM EDT
0.6075
0.00 (0.00%)
After-hours: Sep 8, 2026, 4:00 PM EDT
Adagio Medical Holdings Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
41
Market Cap
13.19M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 602.00K | 302.00K | 100.67% |
| Dec 31, 2023 | 300.00K | 111.00K | 58.73% |
| Dec 31, 2022 | 189.00K | -81.00K | -30.00% |
| Dec 31, 2021 | 270.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| IRIDEX | 51.57M |
| Trinity Biotech | 43.79M |
| Lifeward | 21.82M |
| Pulsenmore | 14.13M |
| NeuroOne Medical Technologies | 12.47M |
| Picard Medical | 6.30M |
| Biomerica | 4.45M |
| IceCure Medical | 3.95M |
ADGM News
- 4 weeks ago - Adagio Medical Reports Second Quarter 2026 Results - Business Wire
- 4 weeks ago - Adagio Medical Holdings Quarterly report: Q2 2026 - Filings
- 4 weeks ago - Adagio Medical Holdings Earnings release: Q2 2026 - Filings
- 5 weeks ago - Adagio Medical treats first patient with vCLAS Ultra ULTA system - TheFly
- 5 weeks ago - Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System - Business Wire
- 2 months ago - Adagio Medical Holdings Transcript: AGM 2026 - Transcripts
- 3 months ago - Adagio Medical initiated with a Buy at Lucid Capital - TheFly
- 3 months ago - Adagio Medical submits PMA application to FDA for vCLAS Ventricular Ablation - TheFly